Assessing the impact of socioeconomic status on incidental lung nodules at an urban safety net hospital.
Deprivation
Disadvantage
Disparity
Inequity
Lung cancer
Lung nodule
Socioeconomic
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
23 Nov 2023
23 Nov 2023
Historique:
received:
10
08
2023
accepted:
20
10
2023
medline:
27
11
2023
pubmed:
24
11
2023
entrez:
23
11
2023
Statut:
epublish
Résumé
Lower socioeconomic status has been identified as an emerging risk factor for health disparities, including lung cancer outcomes. Most research investigating these outcomes includes patients from formal lung cancer screening programs. There is a paucity of studies assessing the relationship between socioeconomic status and incidental lung nodules. This study aimed to investigate the association between socioeconomic status and the size of incidental lung nodules on initial presentation at an urban safety net hospital, which did not have a formal lung cancer screening program or incidental lung nodule program. A retrospective chart review was conducted on patients with incidental lung nodules on CT chest imaging who were referred from primary care to a pulmonology clinic at a safety net hospital. Patients with incomplete nodule characteristics information were excluded. Data on demographics, comorbidities, smoking history, insurance type, immigration status, and geographical factors were collected. Less commonly studied determinants such as crime index, cost of living, and air quality index were also assessed. Logistic regression analysis was performed to assess relationships between nodule size and socioeconomic determinants. Out of 3,490 patients with chest CT scans, 268 patients with ILNs were included in the study. 84.7% of patients represented racial or ethnic minorities, and most patients (67.8%) had federal insurance. Patients with non-commercial insurance were more likely to have larger, inherently higher-risk nodules (> 8 mm) compared to those with commercial insurance (OR 2.18, p 0.01). Patients from areas with higher unemployment rates were also less likely (OR 0.75, p 0.04) to have smaller nodules (< 6 mm). Patients representing racial or ethnic minorities were also more likely to have nodules > 8 mm (OR 1.6, p 0.24), and less likely to have nodules < 6 mm (OR 0.6, p 0.32), however, these relationships were not statistically significant. This study found that lower socioeconomic status, indicated by having non-commercial insurance, was associated with larger incidental lung nodule size on initial presentation. While it is established that socioeconomic status is associated with disparities in lung cancer screening, these findings suggest that inequalities may also be present in those with incidental lung nodules. Further research is needed to understand the underlying mechanisms and develop interventions to address these disparities in incidental lung nodule evaluation and improve outcomes.
Identifiants
pubmed: 37996867
doi: 10.1186/s12890-023-02726-8
pii: 10.1186/s12890-023-02726-8
pmc: PMC10668357
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
469Investigateurs
Prama Rashmi
(P)
Olva Bess
(O)
Haris Asif
(H)
Ifediba Nwachukwu
(I)
Opeyemi Aroyewun
(O)
Alberto Martinez
(A)
Informations de copyright
© 2023. The Author(s).
Références
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
N Engl J Med. 2013 May 23;368(21):1980-91
pubmed: 23697514
J Natl Cancer Inst. 2010 Dec 1;102(23):1771-9
pubmed: 21119104
Am J Respir Crit Care Med. 2023 Mar 15;207(6):e31-e46
pubmed: 36920066
Ann Thorac Surg. 2020 May;109(5):1544-1550
pubmed: 31981498
J Environ Public Health. 2017;2017:2819372
pubmed: 28408935
Clin Gastroenterol Hepatol. 2020 Nov;18(12):2667-2678.e2
pubmed: 32634626
Respiration. 2022;101(11):1024-1034
pubmed: 36228594
Surgery. 2019 Dec;166(6):1099-1104
pubmed: 31296429
World J Clin Cases. 2021 Aug 16;9(23):6734-6746
pubmed: 34447820
Am J Respir Crit Care Med. 2020 Oct 1;202(7):e95-e112
pubmed: 33000953
Lancet Respir Med. 2021 Jul;9(7):689-691
pubmed: 33965004
Lancet. 2023 Feb 4;401(10374):390-408
pubmed: 36563698
Prev Med Rep. 2018 Feb 03;10:49-54
pubmed: 29552458
Am J Respir Crit Care Med. 2015 Nov 15;192(10):1208-14
pubmed: 26214244
BMC Pulm Med. 2020 Apr 29;20(1):115
pubmed: 32349709
Cancers (Basel). 2022 Jan 13;14(2):
pubmed: 35053559
Annu Rev Sociol. 2010 Aug;36:349-370
pubmed: 21909182
J Thorac Dis. 2021 Jun;13(6):3745-3757
pubmed: 34277066
Oncologist. 2020 May;25(5):431-437
pubmed: 31876321
Chest. 2021 Jun;159(6):2477-2482
pubmed: 33434500
J Clin Oncol. 2022 Jul 1;40(19):2094-2105
pubmed: 35258994
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
BMJ Open. 2018 Sep 10;8(9):e021059
pubmed: 30206077
J Public Health (Oxf). 2010 Jun;32(2):210-8
pubmed: 19892784
Radiology. 2017 Jul;284(1):228-243
pubmed: 28240562